Bausch+Lomb Results Presentation Deck slide image

Bausch+Lomb Results Presentation Deck

Reconciliation of Reported Net Income (Loss) to EBITDA (non-GAAP)¹ and Adjusted EBITDA (non-GAAP)¹ ($M) BAUSCH + LOMB Net (loss) income attributable to Bausch + Lomb Corporation $ Interest expense, net (Benefit from) provision for income taxes Depreciation and amortization EBITDA Adjustments: Asset impairments 1. 2. Restructuring, integration and transformation costs Acquisition-related costs and adjustments (excluding amortization of intangible assets) Share-based compensation Separation costs and separation-related costs Other adjustments: Litigation and other matters 2 Acquired in-process research and development costs ² Other Adjusted EBITDA (non-GAAP)¹ Three Months Ended December 31, $ 2022 (1) 44 (2) 93 134 21 1 17 7 1 181 $ $ 2021 51 32 100 183 1 4 17 1 (1) 4 7 216 $ $ Twelve Months Ended December 31, 2022 6 140 58 379 583 1 36 (4) 62 35 1 6 720 $ $ 2021 182 125 415 722 12 11 62 3 (1) 5 7 821 This is a non-GAAP measure or non-GAAP ratio. See Slide 2 and Non-GAAP Appendix for further information on non-GAAP measures and ratios. Prior to 2022, in calculating Adjusted EBITDA, the Company had excluded expenses associated with acquired IPR&D. Beginning in 2022, the Company no longer excludes acquired IPR&D in its calculation of Adjusted EBITDA. The Company is making this change to align with evolving practice in this regard. The Company is making this change for 2022 periods and onwards and has not made this change for periods prior to 2022. The Company believes these costs are not material for the periods presented. In particular, there was no acquired IPR&D in the fourth quarter of 2022 and there was less then $1 million in aggregate acquired IPR&D for the twelve months ended December 31, 2022. For 2021, there was $4 million in the fourth quarter of 2021 and there was $5 million in aggregate acquired IPR&D for the twelve months ended December 31, 2021. 37
View entire presentation